Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection

Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection

Like other organs, brain functions diminish with age. Furthermore, for a variety of neurological disorders—including Alzheimer’s disease—age is one of the higher-risk factors. Since in many Western countries the average age is increasing, determining approaches for decreasing the effects of aging on...

Full description

Bibliographic Details
Main Authors: Osama Elsallabi, Antonia Patruno, Mirko Pesce, Amelia Cataldi, Simone Carradori, Marialucia Gallorini
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Molecules
Subjects:
fisetin
senescence
neuroinflammation
neuroprotection
senolytic drug
in silico evaluation
Online Access:https://www.mdpi.com/1420-3049/27/3/738

Internet

https://www.mdpi.com/1420-3049/27/3/738

Similar Items